Clinical Trial Update: Utidelone Treated for the Recurrent or Metastatic Urothelial Carcinoma [Phase 2]

View source ↗

Summary

Phase 2 trial update for Utidelone in metastatic urothelial carcinoma is currently labeled as unknown status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Urothelial Carcinoma

Drugs mentioned

• Utidelone (utidelone)

Snippet

Sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | Conditions: Metastatic Urothelial Carcinoma | Phase 2 | Status: UNKNOWN